feed,title,long_url,short_url
Benzinga,FDA Allows Resumption Of BioNTech/MediLink Therapeutics Partnered Phase 1 Study For Cancer Drug With Lower Dose,https://benzinga.com/general/biotech/24/08/40440731/fda-allows-resumption-of-biontechmedilink-therapeutics-partnered-phase-1-study-for-cancer-drug-wi,https://da.gd/NpK6Bl
